Effect levetiracetam drug on the liver and kidney of pregnant albino rats

View at publisher Summarise with VIRAT
Authors: Ola Abbas Nawaf, Shaymaa Malik Yasir
Cited by: 0
References: 25

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

One of the most widely prescribed drugs for epilepsy is the second-generation antiepileptic medicine levetiracetam. The aim of this study was to examine the effects of levetiracetam on the liver and kidneys of pregnant albino rats when it was administered in a therapeutic dose. Materials and techniques for the duration of their pregnancy, 44 pregnant rats were divided into three groups and fed distilled water. Rats in groups II and III received levetiracetam in two dosages of 100 and 200 mg/kg each throughout their pregnancies. Both groups' kidneys and livers were taken out once the experiment was over and looked at under a light microscope. Levetiracetam therapy led to histopathological changes in the liver and kidney of pregnant albino rats. These abnormalities included central vein dilatation and congestion, Bowman's space extension, severe glomerular atrophy, hepatic cord irregularity, and urinary tubule lining disruption. The pregnant albino rats' liver and kidneys were harmed by levetiracetam. Further research is required to determine the machine of levetiracetam toxicity.

Fields of Study & Subjects

Pharmacological Effects and Toxicity Studies Drug-Induced Hepatotoxicity and Protection Pesticide Exposure and Toxicity

Publication details

Journal / source
AIP conference proceedings
Volume
3405
Pages
030058–030058
Publication date
1 January 2026
Language
EN